Skip to content
Trial Eligibility
Menu

Ulcerative Colitis Clinical Trials near New York, NY

26 studies for Ulcerative Colitis are recruiting at 63 sites within 50 miles of New York, New York, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Ulcerative Colitis trials in the US or all trials near New York.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Ulcerative Colitis studies enrolling near New York

Showing 26 studies, nearest first.
  1. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

    NCT07184996

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: Lenox Hill Hospital - Site Number: 8400052 (New York, NY); Manhattan Clinical Research, LLC - Site Number: 8400069 (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    10 sites within 50 mi
  2. A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

    NCT07470879

    • Phase 2
    • Ages 2 to 11 years
    • Sex: All

    Nearest sites: Fink Children's Ambulatory Care Center (New York, NY); Kimmel Pavilion - NYU Langone (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  3. A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

    NCT06581328

    • Phase 4
    • Ages 18 to 80 years
    • Sex: All

    Nearest sites: New York Gastroenterology Associates (New York, NY); IMIDeology (Elmhurst, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  4. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    NCT03816345

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Laura and Isaac Perlmutter Cancer Center at NYU Langone (New York, NY); NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  5. A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

    NCT07196748

    • Phase 3
    • Ages 12 years and older
    • Sex: All

    Nearest sites: Icahn School of Medicine at Mount Sinai (New York, NY); Inflammatory Bowel Disease Center at NYU Langone (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  6. Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

    NCT06937086

    • Phase 3
    • Ages 18 to 70 years
    • Sex: All

    Nearest sites: Icahn School of Medicine at Mount Sinai (New York, NY); New York Gastroenterology Associates (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  7. A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

    NCT07185009

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: New York Gastroenterology Associates - Site Number: 8400009 (New York, NY); Weill Cornell Medicine - NewYork-Presbyterian Hospital - Site Number: 8400040 (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  8. Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

    NCT05230173

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Cornell University (New York, NY); NYU Langone Health (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  9. A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

    NCT06095128

    • Phase 4
    • Ages 18 to 65 years
    • Sex: All

    Nearest sites: NYU Langone Health (New York, NY); Weill Cornell Medical College- New York Presbyterian Hospital (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  10. An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

    NCT06398626

    • Observational
    • Ages 18 to 64 years
    • Sex: All

    Nearest sites: Lenox Hill Hospital, Northwell Health (New York, NY); NYU Langone Health (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  11. BOOM-IBD2 Pivotal Clinical Trial

    NCT06571669

    • Interventional
    • Ages 18 to 85 years
    • Sex: All

    Nearest sites: Columbia University Irving Medical Center/New York Presbyterian Hospital (New York, NY); Northwell Health North Shore University Hospital (Manhasset, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  12. A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis

    NCT07158242

    • Phase 3
    • Ages 2 to 17 years
    • Sex: All

    Nearest sites: NYU Langone Health (New York, NY); Northwell Health (Lake Success, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  13. A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

    NCT04844606

    • Phase 3
    • Ages 2 to 19 years
    • Sex: All

    Nearest site: Icahn School of Medicine at Mount Sinai (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

    NCT05076175

    • Phase 2/3
    • Ages 2 to 17 years
    • Sex: All

    Nearest site: Columbia University Medical Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

    NCT06651281

    • Phase 3
    • Ages Any age
    • Sex: All

    Nearest site: New York Gastroenterology Associates ( Site 0253) (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

    NCT06750731

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: NYU Langone Health (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

    NCT07012395

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Site 037 (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

    NCT07113522

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: Mirador Therapeutics Selected Site (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. Zymfentra (Infliximab-dyyb) REal World Cohort STudy

    NCT07237516

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: New York University (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

    NCT07577856

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: New York Gastroenterology Associates (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

    NCT07697456

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: New York Gastroenterology Associates - Upper East Side /ID# 281767 (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

    NCT06979336

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Intercity Gastroenterology (Fresh Meadows, NY)

    Distance to nearest recruiting site
    ~11 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

    NCT04314375

    • Phase 4
    • Ages 5 to 17 years
    • Sex: All

    Nearest site: Bausch Health Site 006 (The Bronx, NY)

    Distance to nearest recruiting site
    ~12 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

    NCT07845487

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Site US-014 (Clifton, NJ)

    Distance to nearest recruiting site
    ~13 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

    NCT07071519

    • Phase 3
    • Ages 2 to 17 years
    • Sex: All

    Nearest site: Goryeb Children's Hospital /ID# 271801 (Morristown, NJ)

    Distance to nearest recruiting site
    ~26 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

    NCT07415044

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: Saint Peter's University Hospital (New Brunswick, NJ)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining an Ulcerative Colitis clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.